Baillie Gifford & Co. Trims Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Baillie Gifford & Co. reduced its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 20.9% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 170,750 shares of the biotechnology company's stock after selling 45,174 shares during the quarter. Baillie Gifford & Co. owned 0.22% of Axon Enterprise worth $101,480,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Prestige Wealth Management Group LLC raised its holdings in Axon Enterprise by 115.8% in the 3rd quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new position in shares of Axon Enterprise in the fourth quarter worth $40,000. Brooklyn Investment Group bought a new position in shares of Axon Enterprise during the third quarter valued at $41,000. Y.D. More Investments Ltd purchased a new stake in shares of Axon Enterprise during the fourth quarter valued at $45,000. Finally, Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% in the 3rd quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company's stock worth $48,000 after buying an additional 55 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the business's stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now directly owns 128,542 shares in the company, valued at approximately $84,168,016.18. The trade was a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock worth $5,631,561 over the last quarter. Insiders own 6.10% of the company's stock.

Remove Ads

Axon Enterprise Price Performance

NASDAQ AXON traded down $28.59 during trading hours on Friday, reaching $513.22. The company's stock had a trading volume of 1,453,359 shares, compared to its average volume of 719,192. Axon Enterprise, Inc. has a 1 year low of $265.32 and a 1 year high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $39.13 billion, a price-to-earnings ratio of 132.62, a PEG ratio of 5.95 and a beta of 1.05. The firm's 50-day moving average price is $619.94 and its 200-day moving average price is $517.11.

Analysts Set New Price Targets

A number of analysts have recently issued reports on AXON shares. The Goldman Sachs Group raised their price target on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "hold" rating and set a $625.00 target price on the stock. in a report on Thursday. Needham & Company LLC boosted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a "buy" rating in a research note on Friday, November 8th. Northcoast Research downgraded Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday. Finally, JMP Securities lifted their price objective on Axon Enterprise from $610.00 to $725.00 and gave the stock a "market outperform" rating in a report on Tuesday, February 4th. Three investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus target price of $561.31.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.